New insights into a Parkinson’s disease protein
Alpha synuclein's non-amyloidal component (NAC) aids the protein's movement through axons. When the NAC region is removed, alpha-synuclein did not move within axons. ... Read More...
Parkinson’s disease
Probiotic could guard against Parkinson’s
Building on previous research that links gut bacteria to the development of Parkinson's disease, researchers identified a probiotic which prevents the formation of alpha-synuclein.... Read More...
Up to 10,000 people could be living with rare neurological disorders
Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), two atypical parkinsonian syndromes, may be twice as common as previously believed, researchers report.... Read More...
Dopamine fasting: an expert reviews the latest craze in Silicon Valley
The latest Silicon Valley crazy of dopamine fasting promises to "reset" the brain to be more effective and appreciate the smaller things in life more easily, but does it work? Researchers look at the effect of dopamine fasting on brain health.... Read More...
Scientists discover medicinal cannabis substitute for treating Parkinson’s disease
HU-308, a cannabis substitute, can reduce L-dopa induced dyskinesia in Parkinson's patients.... Read More...
Increased use of antibiotics may predispose to Parkinson’s disease
Excessive exposure to certain antibiotics can predispose a person to Parkinson's disease, with a delay of onset of up to 15 years.... Read More...
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Study reflects on the possible use of fecal microbiome transplants and pre/probiotics to help with the treatment of Parkinson's disease. Findings reveal fecal transplants have not yet been proven to be effective for motor symptoms associated with the condition, and probiotics have only been shown to assist with constipation.... Read More...
Targeting alpha-synuclein in the gut may slow down Parkinson’s disease
Scientists are conducting experiments to see if targeting the enteric nervous system with a compound can inhibit the aggregation of alpha-synuclein and slow the progression of Parkinson's disease.... Read More...
Inflammatory bowel disease appears to impact risk of Parkinson’s disease
Study provides new insights into how the immune system and inflammation play a role in the development and progression of Parkinson's disease.... Read More...
What do we know about the gut microbiota in Parkinson’s disease?
Researchers propose future gut microbiome studies related to Parkinson's disease should address questions relevant to patient care.... Read More...
Where does Parkinson’s disease start? In the brain or gut? Or both?
Lewy body disorders, including Parkinson's disease and Lewy body dementia, comprise of two distinct subtypes. One subtype originates in the peripheral nervous system (PNS) of the gut and spreads to the brain. The other originates in the brain, or enters the brain via the olfactory system, before spreading to the brainstem and PNS.... Read More...
Exposure to environmental PCBs impairs brain function in mice
Polychlorinated biphenyls (PCBs), chemicals commonly used during the 20th century as flame retardants and in industrial products, disrupt the performance of astrocytes, leading to impaired function. Environmental exposure to PCBs could contribute to a range of neurodegenerative diseases.... Read More...